Cite Filings / PLX / 0001104659-20-046926

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Protalix BioTherapeutics, Inc. Filed 2020-04-15 Acc 0001104659-20-046926

Documents 1

DEF 14A Proxy Statement , tm2015338-1_def14a.htm

Around this filing

2021-06-04 DEF 14A Proxy Statement
2020-04-22 UPLOAD SEC-generated Letter
2020-04-17 S-3 Registration Statement
2020-04-15 DEF 14A Proxy Statement
2020-04-13 4 Director bought 64,000 shares at $2.43 ($155,264)
2019-10-15 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2015338-1_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…